SCHEMBL18154525

SCHEMBL18154525

[O-][n+]1ccc(OCc2ccccc2F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.57
PARP15 Q460N3 2/20 0.53
PARP10 Q53GL7 2/20 0.53
PARP14 Q460N5 1/20 0.53
IDO1 P14902 2/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
SCN3A Q9NY46 2/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RECQL P46063 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PKM P14618 1/20 0.45
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17644774 0.81 MAOB (0.68) MAOBPARP15PARP10PARP14IDO1
SCHEMBL4380683 0.80 MAOB (0.55) MAOBIDO1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL28551904 0.80 MAOB (0.69) MAOBPARP15PARP10PARP14IDO1
SCHEMBL12423201 0.78 MAOB (0.69) MAOBPARP15PARP10PARP14IDO1
SCHEMBL3625841 0.77 MAOB (0.67) MAOBPARP15PARP10PARP14IDO1
SCHEMBL311630 0.75 MAOB (0.65) MAOBPARP15PARP10PARP14IDO1
SCHEMBL22546708 0.75 MAOB (0.65) MAOBPARP15PARP10PARP14IDO1
SCHEMBL21340831 0.75 MAOB (0.65) MAOBPARP15PARP10PARP14IDO1
SCHEMBL863430 0.75 MAOB (0.60) MAOBPARP15PARP10PARP14IDO1
SCHEMBL17804382 0.75 MAOB (0.65) MAOBPARP15PARP10PARP14IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286193-B1 INDOLE DERIVATIVES RICHTER GEDEON NYRT (HU) 2020-05-27 EP disclosed
US-10329296-B2 Indole derivatives RICHTER GEDEON NYRT. (HU) 2019-06-25 US disclosed
US-20180093989-A1 INDOLE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2018-04-05 US disclosed
EP-3286193-A1 INDOLE DERIVATIVES Richter Gedeon Nyrt. (HU) 2018-02-28 EP disclosed
WO-2016166684-A1 INDOLE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329296-B2 Indole derivatives TPH1, MCHR1, MC1R MAOB 67/4885PARP15 3491/4885PARP10 3530/4885
US-20180093989-A1 INDOLE DERIVATIVES MC1R, MCHR1, TPH1 MAOB 72/4885PARP15 3490/4885PARP10 3638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.